Arjun Mehta, MD
Clinical Cardiac Electrophysiology · Chicago, ILNPI 1801238449
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (46.3%), food and beverage and grants — rather than concentrated in one kind of arrangement. 30 manufacturers reported payments, led by Medtronic at 26.0% of the total.
Across 779 payments — averaging $195.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$40K
- Biotronik Inc.$37K
- Boston Scientific$37K
- Abbott$21K
- Biosense Webster, Inc.$3K
- Atricure, Inc.$3K
- plus $11K from 24 others
What the payments were for
- Consulting fees$7,4755%
- Speaking & faculty fees$7,5005%
- Grants$29,70819%
- Travel & lodging$70,58746%
- Food & beverage$37,10224%
- Education$100%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 205 | $39,599 |
| Biotronik Inc. | 123 | $37,455 |
| Boston Scientific | 160 | $36,995 |
| Abbott | 141 | $21,131 |
| Biosense Webster, Inc. | 43 | $3,172 |
| Atricure, Inc. | 11 | $2,581 |
| Altathera Pharmaceuticals LLC | 3 | $2,184 |
| Medical Device Business Services, Inc. | 11 | $2,082 |
| Philips North America LLC | 13 | $1,895 |
| Siemens Medical Solutions USA, Inc. | 2 | $1,718 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 12 | $766 |
| Elutia, Inc. | 16 | $610 |
| Cardiva Medical, Inc. | 6 | $429 |
| Johnson & Johnson | 8 | $359 |
| Abiomed | 3 | $206 |
| Kestra Medical Technology Services, Inc. | 1 | $188 |
| Volta Medical Inc | 1 | $163 |
| Novartis | 4 | $161 |
| Regeneron Healthcare Solutions, Inc. | 2 | $135 |
| Sanofi-aventis U.S. LLC | 1 | $115 |
| Impulse Dynamics (USA) Inc. | 1 | $95 |
| Inari Medical, Inc. | 1 | $95 |
| E.r. Squibb & Sons, L.L.C. | 3 | $52 |
| Vital Connect, Inc | 2 | $42 |
| Pfizer | 1 | $39 |
| Angiodynamics, Inc. | 1 | $29 |
| Intuitive Surgical | 1 | $29 |
| Cook Medical LLC | 1 | $27 |
| AstraZeneca | 1 | $18 |
| Amgen | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Acticor 7 VR-T DX$14,113
- BioMonitor$13,485
- Solia$13,344
- Rivacor 7 DR-T$13,198
- Edora 8 DR-T$13,198
- Farapulse$6,064
- CLINICAL TRIAL PRODUCT$4,375
- PRO-Kinetic Energy$4,316
- Carto 3$4,000
- ENSITE PRECISION$3,849
- GENERAL BRADY$3,750
- EMBLEM S ICD ELECTRODE DELIVERY SYSTEM$3,750
- Sotalol Hydrochloride$2,098
- AVEIR$2,044
- SYNERGY ABLATION SYSTEM$2,009
- GENERAL - THERAPIES$1,823
- EnSite Precision Cardiac Mapping System$1,743
- Micra$1,694
- Ensite Cardiac Mapping System$1,354
- ENSITE$1,291
How this compares
$152,382 in reported general payments places this provider in the 85th percentile of 158 clinical cardiac electrophysiology providers in Illinois.
See all clinical cardiac electrophysiology providers in Illinois →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 313 | $327,097 |
| XareltoRivaroxaban | 18 | $24,133 |
| EntrestoSacubitril/Valsartan | 14 | $14,766 |
| Flecainide Acetate | 47 | $2,100 |
| Metoprolol Succinate | 82 | $1,602 |
| Amiodarone Hcl | 64 | $852 |
| Metoprolol Tartrate | 24 | $207 |
| Carvedilol | 29 | $164 |
| Furosemide | 12 | $39 |
| Amlodipine Besylate | 11 | $32 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $39 | $327,097313 claims |
| Johnson & JohnsonXarelto | $359 | $24,13318 claims |
| NovartisEntresto | $161 | $14,76614 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 158 clinical cardiac electrophysiology providers in Illinois.
Other clinical cardiac electrophysiology in Chicago
- Roderick TungChicago$795K
- Bradley KnightChicago$661K
- Gaurav UpadhyayChicago$593K
- Hany DemoChicago$297K
- Nishant VermaChicago$232K
- Susan KimChicago$186K
- Martin BurkeChicago$183K
- Rod PassmanChicago$92K
- Zaid AzizChicago$74K
- Lalit WadhwaniChicago$73K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.